CClinicalTrials.gg
CompletedNCT02688777BLASTUpdated Nov 24, 2023Results posted

A Novel Strategy to Decrease Fall Incidence Post-Stroke

An interventional study of Backward Walking Training in Stroke, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-11-24.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. Contributing to these costs is the incidence of falls. Falls are a costly complication for Veterans with stroke as they lead to an increased incidence of fractures, depression, and mortality. New strategies are needed to help Veterans post-stroke regain their ability to safely walk without increasing their risk of falling as well as readily identify those who are a fall risk. This study addresses both of these needs as it will 1) investigate a new treatment approach, backward walking training, to determine if it will decrease fall incidence in the first year post-stroke and 2) determine if backward walking speed early after a stroke can identify those that are at risk for future falls.

Read the detailed description

Approximately 15,000 Veterans are hospitalized for stroke each year. Persistent walking and balance deficits contribute to long-term disability and a high incidence of falls. Falls are a common and costly complication of stroke; between 40% and 70% of affected individuals fall within the first year. Falls lead to fear of falling, limitations in self-care and increased dependence. Of greater concern, they lead to serious adverse events, including fractures, depression and mortality. A primary goal of stroke rehabilitation is to improve mobility despite persistent motor, balance and visual-spatial deficits. However, this goal has a down side since it increases fall risks. Here, the investigators propose a novel therapeutic strategy to improve ambulation while decreasing the risk of falls: Backward Walking Training (BWTraining).

The investigators' central hypothesis is that a 6-week BWTraining program at 2-months post-stroke is superior to standard care in reducing falls within the 1st year post-stroke. Identification of those at risk for falling is a necessary component of post-stroke rehabilitation to implement pro-active measures to decrease risk once individuals rejoin community living. Recent research in a cohort of elderly adults determined that maximal Backward Walking Speed (BWSpeed) (not forward) identified individuals that had experienced a fall in the previous six months,6 suggesting that BWSpeed could be a simple, inexpensive screening tool to identify individuals at risk of falling. With a randomized, blinded design, the investigators propose to prospectively assess the value of BWSpeed as a tool to predict future falls.

A notable post-stroke conundrum is that increased mobility may increase fall risk.5 On the other hand, limiting mobility leads to a multitude of inactivity-associated deficits, including recurrent stroke.

To date, no intervention has demonstrated efficacy for improving walking while minimizing fall risk. BWTraining may be a simple and effective intervention to achieve both goals. In the investigators' recent randomized controlled pilot trial (RCT), individuals with sub-acute stroke who participated in a BWTraining demonstrated 3-fold improvement in backward and forward walking speed and fall self-efficacy. Further, BWTraining caused 75% greater improvement in balance versus those in a dose-matched balance training group. At the 3-month follow-up assessment, BWSpeed of the BWTraining group averaged 0.63 m/s, exceeding the threshold for fall risk in elderly adults.

Given the success of the investigators' pilot intervention, a larger and more rigorous trial is needed to demonstrate reduced fall incidence over an extended follow-up period. The investigators designed this RCT to address three specific aims:

Aim #1: Test the hypothesis that 1-year fall incidence is decreased for participants randomized to BWTraining administered at 2-months post-stroke (versus usual care comparison group).

Hypothesis #1a: BWTraining at 2-months post-stroke reduces the number of falls over the next year.

Hypothesis #1b: BWTraining at 2-months post-stroke increases gait speed, improves balance and increases balance confidence over the next year.

Aim #2: Test the hypothesis that BWTraining at 2 months (immediate) vs. 1-year (delayed) post-stroke is more effective at improving BWSpeed.

Hypothesis #2a: BWSpeed improvement from 2- to 14-months post-stroke is greater when BWTraining is delivered at 2 months versus 1 year post-stroke.

Hypothesis #2b: Improvements in forward gait speed, Functional Gait Assessment and Activities-Balance Confidence Scale from 2- to 14-months post-stroke are greater when BWTraining is delivered at 2 months versus 1 year post-stroke.

Aim #3: This exploratory aim will test the hypothesis that BWSpeed at 2-months post-stroke is a significant predictor of fall incidence over the next year 1 year period, after adjusting for other covariates.

Hypothesis #3: BWSpeed at 2-months will be a significant predictor of fall incidence during the first year post-stroke, after adjusting for other covariates.

This study is significant since it concerns a novel strategy to improve ambulation while minimizing the risk of falling after a stroke. BWTraining is highly novel, is easy to administer and exciting preliminary data suggest that is has major potential as a therapeutic tool. In addition, the investigators will determine the potential of BWSpeed (a simple, clinically relevant screening tool) to identify those at risk for future falls.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Rehabilitation
  • Gait
  • Postural Balance
  • Exercise
  • Accidental Falls
  • Kinesiology, Applied
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 62 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Berg Balance Scale \< 42
  • Self-selected 10 meter gait speed \< 0.8 m/s
  • Diagnosis of unilateral stroke
  • > 2 months \< 4 months post-stroke
  • Able to ambulate at least 10 feet with maximum 1 person assist
  • Medically stable
  • 18-85 years of age
  • Physician approval for patient participation

Exclusion criteria

Exclusion Criteria:

  • Presence of neurological condition other than stroke
  • Serious cardiac conditions

    • hospitalization for myocardial infarction or heart surgery within 3 months
    • history of congestive heart failure
    • documented serious and unstable cardiac arrhythmias
    • hypertrophic cardiomyopathy
    • severe aortic stenosis
    • angina or dyspnea at rest or during activities of daily living
  • Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
  • Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity

    • knee flexion contracture of -10
    • knee flexion Range Of Motion \< 90
    • hip flexion contracture > 25
    • ankle plantar flexion contracture > 15
  • Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest, that cannot be medically controlled into the resting range of 180/100 mmHg
  • Pain upon ambulation
  • Receiving physical therapy services for mobility and/or gait
  • Living in a skilled nursing facility
  • Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking less than 200 meters
  • History of serious chronic obstructive pulmonary disease or oxygen independence
  • Non-healing ulcers on the lower extremity
  • Uncontrollable diabetes with recent weight loss, diabetic coma or frequent insulin reactions
  • On renal dialysis or presence of end stage liver disease
  • Pulmonary embolism within previous 6 months
  • History of major head trauma
  • History of sustained alcoholism or drug abuse in the last six months
  • Intracranial hemorrhage related to aneurysmal rupture or an arteriovenous malformation
  • Current enrollment in a clinical trial to enhance stroke motor recovery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Immediate Backward Walking Training

    Individuals will participate in 18 sessions of Backward Walking training immediately following baseline assessment.

    Behavioral: Backward Walking Training

  • Active comparator
    Delayed Backward Walking Training

    Individuals will participate in 18 sessions of Backward Walking training at 1-year post-strokeD

    Behavioral: Backward Walking Training

Interventions

  • BehavioralBackward Walking Training

    Backward Walking Training will occur both on a treadmill and overground. In brief, BWTraining will consist of 20-30 minutes of step training with a Body Weight Support and Treadmill system (BWST), rest periods provided as warranted, with manual assistance provided by trainers, followed by 15 minutes of overground gait training. A 20-30 min period of actual stepping is the goal for the intervention sessions on the treadmill with rest periods as needed. Each training session may last up to 1 hour and 30 minutes including time for warm-up, stretching, and cool down. Participants will be fitted with a harness around their hips and torso, which will be attached to an overhead support system directly above the treadmill. From a stationary position, the treadmill belt will gradually be increased in speed with intervention trainers assisting participant to step backward with their paretic leg, their non-paretic leg (if needed) and at the hips for weight-shift.

06

What researchers measure

Primary outcomes

  1. Fall Incidence (Number of Falls)

    Fall incidence will be monitored using the international standards for defining and reporting falls,60 including the following definition for a fall: "A person has a fall if they end up on the ground or floor when they did not expect to. Most often a fall starts while a person is on their feet, but a fall could also start from a chair or bed. If a person ends up on the ground, either on their knees, their belly, their side, their bottom, or their back, they have had a fall." This explanation will be provided to participants and caregivers and printed on monthly calendars issued at randomization. The number of falls will be recorded on a monthly basis and then added across months to determine the number of recorded falls between baseline and 1-year post-stroke.

    Time frame: Number of recorded falls between baseline and 1-year post-stroke

Secondary outcomes

  1. 10 Meter Walk Test

    Individuals will be given a 2 meter warm-up distance for walking, preceding the 10 meter distance and 2 meters beyond the 10 meters to continue walking. The time that it takes to traverse the 10 meters at the subject's usual pace will be recorded.

    Time frame: Change between baseline and 1-year post-stroke

  2. 3-Meter Backward Walk Test

    The test consists of a 1 meter warm-up distance, a timed 3 meter distance, followed by an additional 1 meter to continue walking An average of two trials will be recorded.

    Time frame: Change between baseline and 1-year post-stroke

  3. Functional Gait Assessment

    A 10-item clinical gait and balance test during which participants perform the following activities: walk at normal speeds, at fast and slow speeds, with vertical and horizontal head turns, with eyes closed, over obstacles, in tandem, backward and while ascending and descending stairs. Minimum value: 0 Maximum value: 40 Higher score = better outcome

    Time frame: Change between baseline and 1-year post-stroke

  4. Activities-Specific Balance Confidence Scale

    This 16-item self-report measure is used to assess perceived efficacy (self-reported confidence) in maintaining balance while performing a number of activities common in community-dwelling older adults. Minimum value: 0% Maximum value: 100% Higher score = better outcome

    Time frame: Change between baseline and 1-year post-stroke

  5. Berg Balance Scale

    This tool consists of 14 items that assesses static and dynamic standing balance, ability to sit, stand up and transfer. Minimum Value: 0 Maximum Value 56 Higher score = better outcome

    Time frame: Change between baseline and 1-year post-stroke

  6. Lower-Extremity Fugl-Meyer Motor Score

    This tool consists of 17 items that assess motor control of the lower extremity as participants move their hip, knee and ankle in lying, sitting and standing. Minimum score=0 Maximum score = 34 Higher score = better outcome

    Time frame: Change between baseline and 1-year post-stroke

  7. Four-Step Square Test

    This clinical test of dynamic standing balance examines the ability to step over small objects, change direction and includes taking a backwards step.

    Time frame: Change between baseline and 1-year post-stroke

  8. Stride Time

    Stride time will be captured during forward and backward walking across a pressure-sensitive instrumented walkway.

    Time frame: Change between baseline and 1-year post-stroke

  9. Stride Length

    Stride length will be captured during forward and backward walking across a GAITRite instrumented walkway.

    Time frame: Change between baseline and 1-year post-stroke

  10. Step Time

    Step time will be captured during forward and backward walking across a GAITRite instrumented walkway.

    Time frame: Change between baseline and 1-year post-stroke

  11. Step Length

    Step length will be captured during forward and backward walking across a GAITRite instrumented walkway.

    Time frame: Change between baseline and 1-year post-stroke

  12. Step Width

    Step width will be captured during forward and backward walking across a GAITRite instrumented walkway.

    Time frame: Change between baseline and 1-year post-stroke

07

Results

Posted Nov 24, 2023

Participant flow

Participant flow — Overall Study
MilestoneImmediate Backward Walking TrainingDelayed Backward Walking Training
Started3230
Completed2519
Not completed711

Outcome measures

PrimaryFall Incidence (Number of Falls)

Fall incidence will be monitored using the international standards for defining and reporting falls,60 including the following definition for a fall: "A person has a fall if they end up on the ground or floor when they did not expect to. Most often a fall starts while a person is on their feet, but a fall could also start from a chair or bed. If a person ends up on the ground, either on their knees, their belly, their side, their bottom, or their back, they have had a fall." This explanation will be provided to participants and caregivers and printed on monthly calendars issued at randomization. The number of falls will be recorded on a monthly basis and then added across months to determine the number of recorded falls between baseline and 1-year post-stroke.

Time frame:
Number of recorded falls between baseline and 1-year post-stroke
Reported as:
Number · number of falls
Fall Incidence (Number of Falls)
number of fallsImmediate Backward Walking TrainingDelayed Backward Walking Training
Fall Incidence (Number of Falls)8856
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · Hazard ratio, log: 0.6
Secondary10 Meter Walk Test

Individuals will be given a 2 meter warm-up distance for walking, preceding the 10 meter distance and 2 meters beyond the 10 meters to continue walking. The time that it takes to traverse the 10 meters at the subject's usual pace will be recorded.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · meters/second
10 Meter Walk Test
meters/secondImmediate Backward Walking TrainingDelayed Backward Walking Training
10 Meter Walk Test0.17 ± 0.030.22 ± 0.04
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.37 (A priori threshold for significance is p \< 0.05.) · Mean difference (final values): 0.05
Secondary3-Meter Backward Walk Test

The test consists of a 1 meter warm-up distance, a timed 3 meter distance, followed by an additional 1 meter to continue walking An average of two trials will be recorded.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · meters/second
3-Meter Backward Walk Test
meters/secondImmediate Backward Walking TrainingDelayed Backward Walking Training
3-Meter Backward Walk Test0.13 ± 0.020.19 ± 0.03
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.13 (A priori threshold set for p \< 0.05) · Mean difference (final values): 0.16
SecondaryFunctional Gait Assessment

A 10-item clinical gait and balance test during which participants perform the following activities: walk at normal speeds, at fast and slow speeds, with vertical and horizontal head turns, with eyes closed, over obstacles, in tandem, backward and while ascending and descending stairs. Minimum value: 0 Maximum value: 40 Higher score = better outcome

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · score on a scale
Functional Gait Assessment
score on a scaleImmediate Backward Walking TrainingDelayed Backward Walking Training
Functional Gait Assessment4.8 ± 0.845.6 ± 1.1
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.40 (A priori threshold p \< 0.05 for statistical significance.) · Mean difference (final values): 0.8
SecondaryActivities-Specific Balance Confidence Scale

This 16-item self-report measure is used to assess perceived efficacy (self-reported confidence) in maintaining balance while performing a number of activities common in community-dwelling older adults. Minimum value: 0% Maximum value: 100% Higher score = better outcome

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · percentage of confidence
Activities-Specific Balance Confidence Scale
percentage of confidenceImmediate Backward Walking TrainingDelayed Backward Walking Training
Activities-Specific Balance Confidence Scale15.9 ± 3.421.6 ± 3.5
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.12 · Mean difference (final values): 5.7
SecondaryBerg Balance Scale

This tool consists of 14 items that assesses static and dynamic standing balance, ability to sit, stand up and transfer. Minimum Value: 0 Maximum Value 56 Higher score = better outcome

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · score on a scale
Berg Balance Scale
score on a scaleImmediate Backward Walking TrainingDelayed Backward Walking Training
Berg Balance Scale10.1 ± 1.810.4 ± 0.4
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.43 (A priori threshold set at p \< 0.05 for statistical significance.) · Mean difference (final values): 0.03
SecondaryLower-Extremity Fugl-Meyer Motor Score

This tool consists of 17 items that assess motor control of the lower extremity as participants move their hip, knee and ankle in lying, sitting and standing. Minimum score=0 Maximum score = 34 Higher score = better outcome

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · score on a scale
Lower-Extremity Fugl-Meyer Motor Score
score on a scaleImmediate Backward Walking TrainingDelayed Backward Walking Training
Lower-Extremity Fugl-Meyer Motor Score2.6 ± 0.74.8 ± 0.9
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.02 (A prior threshold for significance set at p \< 0.05) · Mean difference (final values): 2.2
SecondaryFour-Step Square Test

This clinical test of dynamic standing balance examines the ability to step over small objects, change direction and includes taking a backwards step.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · seconds
Four-Step Square Test
secondsImmediate Backward Walking TrainingDelayed Backward Walking Training
Four-Step Square Test20.54 ± 6.8934.49 ± 10.96
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.28 · Mean difference (final values): 13.95
SecondaryStride Time

Stride time will be captured during forward and backward walking across a pressure-sensitive instrumented walkway.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · seconds
Stride Time
secondsImmediate Backward Walking TrainingDelayed Backward Walking Training
Stride Time0.30 ± 0.030.26 ± 0.05
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.22 · Mean difference (final values): 0.04
SecondaryStride Length

Stride length will be captured during forward and backward walking across a GAITRite instrumented walkway.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · centimeters
Stride Length
centimetersImmediate Backward Walking TrainingDelayed Backward Walking Training
Stride Length5.1 ± 0.086.1 ± 0.09
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.10
SecondaryStep Time

Step time will be captured during forward and backward walking across a GAITRite instrumented walkway.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · seconds
Step Time
secondsImmediate Backward Walking TrainingDelayed Backward Walking Training
Step Time.116 ± 0.02.195 ± 0.03
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.09
SecondaryStep Length

Step length will be captured during forward and backward walking across a GAITRite instrumented walkway.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · centimeters
Step Length
centimetersImmediate Backward Walking TrainingDelayed Backward Walking Training
Step Length3.4 ± 1.25.0 ± 1.9
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.11
SecondaryStep Width

Step width will be captured during forward and backward walking across a GAITRite instrumented walkway.

Time frame:
Change between baseline and 1-year post-stroke
Reported as:
Mean · centimeters
Step Width
centimetersImmediate Backward Walking TrainingDelayed Backward Walking Training
Step Width1.2 ± 0.062.2 ± 0.07
Statistical analysis
  • Immediate Backward Walking Training vs Delayed Backward Walking Training · t-test, 2 sided · p = 0.28

Adverse events

Collected over Three years - over the course of the study.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Immediate Backward Walking Training0/32 (0%)8/32 (25%)21/32 (65.6%)
Delayed Backward Walking Training1/30 (3.3%)10/30 (33.3%)18/30 (60%)
Most frequent serious events
Most frequent serious events
EventImmediate Backward Walking TrainingDelayed Backward Walking Training
Inpatient HospitalizationGeneral disorders8/3210/30
Most frequent other events
Most frequent other events
EventImmediate Backward Walking TrainingDelayed Backward Walking Training
Fall without injuryGeneral disorders21/3218/30

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Immediate Backward Walking TrainingDelayed Backward Walking TrainingTotal
<=18 years000
Between 18 and 65 years242044
>=65 years81018
Age, Continuous
Age, Continuous(years)Immediate Backward Walking TrainingDelayed Backward Walking TrainingTotal
Mean59.3 ± 10.857.8 ± 14.558.5 ± 12.7
Sex: Female, Male
Sex: Female, Male(Participants)Immediate Backward Walking TrainingDelayed Backward Walking TrainingTotal
Female111021
Male212041
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Immediate Backward Walking TrainingDelayed Backward Walking TrainingTotal
American Indian or Alaska Native000
Asian202
Native Hawaiian or Other Pacific Islander000
Black or African American121123
White161834
More than one race213
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Immediate Backward Walking TrainingDelayed Backward Walking TrainingTotal
United States323062
08

Study locations

1 site
  • North Florida/South Georgia Veterans Health System, Gainesville, FL
    Gainesville, Florida 32608, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 21, 2022
  • Informed consent form · Oct 20, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02688777
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Feb 23, 2016
Start date
Aug 14, 2017
Primary completion
Sep 30, 2021
Completion
Feb 11, 2022
Results posted
Nov 24, 2023
Last update
Nov 24, 2023

Study contacts

Dorian Kay Rose, PhD MS BS
principal investigator · North Florida/South Georgia Veterans Health System, Gainesville, FL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion